8/102 sources · 2 publishersUpdated Nov 17, 01:10 UTC
Dare Bioscience reports Q3 loss and revenue miss
Dare Bioscience reported third-quarter GAAP EPS of -$0.18, missing estimates by $0.02. Revenue was $47.63K, below the $1.82M consensus and higher than $2,300 a year earlier in the company-reported figures.
Why it matters
The results give investors a quarterly earnings and revenue miss, with revenue materially below consensus. The disclosed shortfalls may weigh on the market’s assessment of the company’s near-term performance.
Key facts
- 1Third-quarter GAAP EPS was -$0.18, a $0.02 miss versus estimates. seekingalpha.com
- 2Third-quarter revenue was $47.63K versus a $1.82M consensus estimate. investing.com
- 3Revenue was reported as $48,000 versus $2,300 a year earlier. seekingalpha.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.